FINAL BILL REPORT
SHB 1765
This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent. |
C 205 L 17
Synopsis as Enacted
Brief Description: Concerning donations to the prescription drug donation program.
Sponsors: House Committee on Health Care & Wellness (originally sponsored by Representatives Irwin, Koster, Volz, Kraft, Stokesbary and Kloba).
House Committee on Health Care & Wellness
Senate Committee on Health Care
Background:
A pharmacy may not accept for return prescription drugs after they have been taken from the premises where sold, distributed, or dispensed, except under limited circumstances. For example, a pharmacy may accept for return drugs legally dispensed by prescription in unit dose forms or in sealed single- or multiple-dose ampoules or vials where the pharmacist can readily determine that entry or attempted entry has not been made and that meet United States Pharmacopeia standards for storage conditions. A pharmacy may also accept controlled substances for purposes of destruction.
Under the Prescription Drug Donation Program, a practitioner, pharmacist, medical facility, drug manufacturer, or drug wholesaler may donate prescription drugs and supplies to a pharmacy for redistribution without compensation. When redistributing donated drugs, priority is given to patients who are uninsured and have an income of 200 percent of the federal poverty level or less. A drug may only be donated if it was stored under required temperature conditions using the drug's time/temperature indicator information and the donor has completed and signed a donor form to release the drug for distribution and certifying that the drug has never been opened, used, adulterated, or misbranded.
Summary:
To be eligible for donation, only drugs equipped with a time/temperature indicator at the point of manufacture must be stored under required temperature conditions using the drugs' time/temperature indicator information.
The donor form for prescription drugs that do not have a time/temperature indicator at the point of manufacture must include an attestation that the drugs have been stored in a manner that adheres to the conditions established by the manufacturer.
Votes on Final Passage:
House | 97 | 0 | |
Senate | 49 | 0 |
Effective: | May 5, 3017 |